ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
0,9115
0,0115
(1,28%)
Geschlossen 02 Februar 10:00PM
0,9115
0,00
(0,00%)
Nach Börsenschluss: 1:46AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,9115
Gebot
-
Fragen
-
Volumen
253.018
0,885101 Tagesbereich 0,93819
0,68 52-Wochen-Bereich 5,22
Marktkapitalisierung
Handelsende
0,90
Handelsbeginn
0,891
Letzte Trade
470
@
0.9115
Letzter Handelszeitpunkt
Finanzvolumen
US$ 228.204
VWAP
0,90193
Durchschnittliches Volumen (3 Mio.)
420.112
Ausgegebene Aktien
19.548.167
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,60
Gewinn pro Aktie (EPS)
-1,52
Erlöse
4,49M
Nettogewinn
-29,74M

Über Palatin Technologies Inc New

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the me... Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Palatin Technologies Inc New is listed in the Pharmaceutical Preparations sector of the Amerikanische Börse with ticker PTN. The last closing price for Palatin Technologies was US$0,90. Over the last year, Palatin Technologies shares have traded in a share price range of US$ 0,68 to US$ 5,22.

Palatin Technologies currently has 19.548.167 shares in issue. The market capitalisation of Palatin Technologies is US$17,59 million. Palatin Technologies has a price to earnings ratio (PE ratio) of -0.60.

PTN Neueste Nachrichten

Palatin Provides Update on Anticipated 2025 Corporate Milestones

Palatin Provides Update on Anticipated 2025 Corporate Milestones PR Newswire CRANBURY, N.J., Jan. 28, 2025 Obesity programs:Phase 2 BMT-801 clinical study with MC4R agonist bremelanotide plus...

Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic Nephropathy

Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic Nephropathy PR Newswire CRANBURY, N.J., Dec. 19, 2024 Open label study designed to evaluate the...

Palatin Announces Exercise of Warrants for Approximately $3.4 Million Gross Proceeds

Palatin Announces Exercise of Warrants for Approximately $3.4 Million Gross Proceeds PR Newswire CRANBURY, N.J., Dec. 16, 2024 CRANBURY, N.J., Dec. 16, 2024 /PRNewswire/ -- Palatin Technologies...

Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis

Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis PR Newswire CRANBURY, N.J., Nov. 25, 2024 Oral PL8177...

Palatin Reports First Quarter Fiscal Year 2025 Operating/Financial Results

Palatin Reports First Quarter Fiscal Year 2025 Operating/Financial Results PR Newswire CRANBURY, N.J., Nov. 14, 2024 Obesity programs:Core focus on obesity includes exploratory co-administration...

Palatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024

Palatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024 PR Newswire CRANBURY, N.J., Nov. 8, 2024 CRANBURY, N.J., Nov. 8, 2024...

Palatin Presents Data on Novel Melanocortin 4 Receptor Selective Oral Small Molecule PL7737 Obesity Program at ObesityWeek® 2024

Palatin Presents Data on Novel Melanocortin 4 Receptor Selective Oral Small Molecule PL7737 Obesity Program at ObesityWeek® 2024 PR Newswire CRANBURY, N.J., Nov. 4, 2024 Oral PL7737 significantly...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0385-4.052631578950.950.990.862967390.90360386CS
4-0.3985-30.41984732821.311.450.863357331.10355141CS
12-0.2585-22.0940170941.171.450.71644201121.01746614CS
26-0.7785-46.06508875741.691.730.683298561.07407323CS
52-4.2185-82.23196881095.135.220.683619631.79380963CS
1560.5115127.8750.48.60.18113547131.30899304CS
2600.241536.04477611940.678.60.181115491870.75742968CS

PTN - Frequently Asked Questions (FAQ)

What is the current Palatin Technologies share price?
The current share price of Palatin Technologies is US$ 0,9115
How many Palatin Technologies shares are in issue?
Palatin Technologies has 19.548.167 shares in issue
What is the market cap of Palatin Technologies?
The market capitalisation of Palatin Technologies is USD 17,59M
What is the 1 year trading range for Palatin Technologies share price?
Palatin Technologies has traded in the range of US$ 0,68 to US$ 5,22 during the past year
What is the PE ratio of Palatin Technologies?
The price to earnings ratio of Palatin Technologies is -0,6
What is the cash to sales ratio of Palatin Technologies?
The cash to sales ratio of Palatin Technologies is 3,96
What is the reporting currency for Palatin Technologies?
Palatin Technologies reports financial results in USD
What is the latest annual turnover for Palatin Technologies?
The latest annual turnover of Palatin Technologies is USD 4,49M
What is the latest annual profit for Palatin Technologies?
The latest annual profit of Palatin Technologies is USD -29,74M
What is the registered address of Palatin Technologies?
The registered address for Palatin Technologies is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Palatin Technologies website address?
The website address for Palatin Technologies is palatin.com
Which industry sector does Palatin Technologies operate in?
Palatin Technologies operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DXFEason Technology Limited
US$ 26,00
(57,29%)
895,49k
SGNSigning Day Sports Inc
US$ 3,73
(45,70%)
58,75M
CLDICalidi Biotherapeutics Inc
US$ 0,7629
(21,95%)
7,23M
XTNTXtant Medical Holdings Inc
US$ 0,6149
(15,50%)
99,96k
NNVCNanoViricides Inc
US$ 1,185
(10,75%)
688,94k
EXODExodus Movement Inc
US$ 50,00
(-18,54%)
155,49k
SENSSenseonics Holdings Inc
US$ 0,9609
(-11,84%)
17,03M
CPHIChina Pharma Holdings Inc
US$ 0,2183
(-9,91%)
325,86k
GOROGold Resource Corporation
US$ 0,3462
(-9,56%)
1,49M
EONREON Resources Inc
US$ 0,82
(-9,50%)
1,63M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 27,02
(-0,48%)
102,62M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 5,82
(1,39%)
81,2M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,3017
(-2,26%)
75,38M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3,565
(7,70%)
70,73M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
US$ 20,61
(0,73%)
67,41M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock